On Invalid Date, Aldeyra Therapeutics (NASDAQ: ALDX) reported Q1 2023 earnings per share (EPS) of -$0.27, up 6.9% year over year. Total Aldeyra Therapeutics earnings for the quarter were -$15.62 million. In the same quarter last year, Aldeyra Therapeutics's earnings per share (EPS) was -$0.29.
As of Q2 2023, Aldeyra Therapeutics's earnings has grown year over year. Aldeyra Therapeutics's earnings in the past year totalled -$60.85 million.
What is ALDX's earnings date?
Aldeyra Therapeutics's earnings date is Invalid Date. Add ALDX to your watchlist to be reminded of ALDX's next earnings announcement.
What was ALDX's revenue last quarter?
On Invalid Date, Aldeyra Therapeutics (NASDAQ: ALDX) reported Q1 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Aldeyra Therapeutics's revenue was $0.00.
What was ALDX's revenue growth in the past year?
As of Q2 2023, Aldeyra Therapeutics's revenue has grown null year over year. Aldeyra Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.